Bharat Biotechs Covaxin Approved For Emergency Use By WHO

Please Subscribe and Get Daily Updates in Your Inbox!!!

Please Subscribe and Get Daily Update in Your Inbox
Loading

05 November 2021 Current Affairs:Bharat Biotech’s Covaxin has been approved by the WHO, with the technical advisory team recommending the India-made vaccine for emergency use in anyone aged 18 and up.

Highlights:
♦ This is a significant step forward in India’s fight against Covid-19.
♦  Covaxin is a vaccine developed by Hyderabad-based Bharat Biotech and the Indian Council of Medical Research. 
♦ It is totally “made in India.” Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson 7 Johnson – Janssen, Moderna, and Sinopharm have all had their Covid-19 vaccines authorized by the WHO for emergency use.
♦ Last month, the technical advisory panel requested additional clarity from Bharat Biotech for its final risk assessment, which caused the emergency listing to be postponed. 
♦ Covaxin has been recommended for emergency use listing by the technical advisory group, which met to make the final decision. 
♦ Covaxin has been shown to be effective against symptomatic COVID-19 at 77.8% and 65.2 percent against the novel Delta variant at 65.2 percent.
 

Leave a Reply

Your email address will not be published.